Erratum: Author correction to "Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry" [Acta Pharmaceutica Sinica B 10 (2020) 789-798]

Ke Tang,Xiaoyu Zhang,Ying Guo

DOI: https://doi.org/10.1016/j.apsb.2024.04.012

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.02.014.].

What problem does this paper attempt to address?

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Lijun Du,Jinhua Shen,John J. Kim,Yunxian Yu,Lu Ma,Ning Dai

DOI: https://doi.org/10.1038/srep46121

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Scientific Reports 6: Article number: 34305; published online: 06 October 2016; updated: 07 April 2017 Affiliation 1 was incorrectly listed as ‘Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang province 310016, China’ in the original version of the Article.
Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Xiang P. Liu,Li J. Gao,Ben T. She,Gui X. Li,Yun R. Wu,Ji M. Xu,Zhong J. Ding,Jian F. Ma,Shao J. Zheng

DOI: https://doi.org/10.1111/pce.14419

2022-01-01

Abstract:In the published article, the author names in the byline which originally appeared as “Xiang P. Liu, Li J. Gao, Ben T. She, Gui X. Li, Yun R. Wu, Ji M. Xu, Zhong J. Ding, Jian F. Ma, Shao J. Zheng” have been corrected to “Xiangpei Liu, Lijun Gao, Bentao She, Guixin Li, Yunrong Wu, Jiming Xu, Zhongjie Ding, Jianfeng Ma, Shaojian Zheng” in the byline and the ORCID ID section. We apologize for this error.
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Author correction to ‘Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects’ [Acta Pharmaceutica Sinica B 13 (2023) 2138–2151]

Wei Wei,Qingxuan Zeng,Yan Wang,Xixi Guo,Tianyun Fan,Yinghong Li,Hongbin Deng,Liping Zhao,Xintong Zhang,Yonghua Liu,Yulong Shi,Jingyang Zhu,Xican Ma,Yanxiang Wang,Jiandong Jiang,Danqing Song

DOI: https://doi.org/10.1016/j.apsb.2023.12.014

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.12.009.].
Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747]

Bo Xiao,Yuqi Liang,Ga Liu,Lingshuang Wang,Zhan Zhang,Libin Qiu,Haiting Xu,Sean Carr,Xiaoxiao Shi,Rui L Reis,Subhas C Kundu,Zhenhua Zhu

DOI: https://doi.org/10.1016/j.apsb.2024.06.005

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2024.02.008.].
Correction: Corrigendum: Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae

Dong, Bo,Xu, Xiaojin,Chen, Guoqing,Zhang, Dandan,Tang, Mingzhi,Xu, Fei,Liu, Xiaohong,Wang, Hua,Zhou, Bo

DOI: https://doi.org/10.1038/srep33939

IF: 4.6

2016-01-01

Scientific Reports

Abstract:Scientific Reports 6: Article number: 30963; published online: 08 August 2016; updated: 30 September 2016 This Article contains a typographical error in the Acknowledgements section. “We would also like to thank Li Xe and Xijiao Song (Zhejiang Academy of Agricultural Sciences, Hangzhou, China) for technical assistance on the confocal microscopic analysis”.
Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Wan Li,Liwen Ren,Xiangjin Zheng,Jinyi Liu,Jinhua Wang,Tengfei Ji,Guanhua Du

DOI: https://doi.org/10.1016/j.apsb.2024.04.025

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2019.12.012.].
RETRACTED: Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes Dis DOI: 10.1016/J.gendis.2020.07.005]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Shi Feng,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2021.09.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.].
Author correction to ‘Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy’ [Acta Pharmaceutica Sinica B 11 (2021) 3508–3526]

Shuyi Wang,Jun Tao,Huaguo Chen,Machender R. Kandadi,Mingming Sun,Haixia Xu,Gary D. Lopaschuk,Yan Lu,Junmeng Zheng,Hu Peng,Jun Ren

DOI: https://doi.org/10.1016/j.apsb.2022.12.015

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.07.006.].
Erratum: Author correction to 'Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' [Acta Pharm Sin B 12 (2022) 4458-4471]

Qiang Niu,Yu Liu,Yujing Zheng,Ziwei Tang,Yuna Qian,Ruogu Qi,Jianliang Shen,Ping Zhao

DOI: https://doi.org/10.1016/j.apsb.2024.02.021

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.11.002.].
Corrigendum to “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” [Genes & Diseases 9(2022) 443-455]

Xiujin Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Shi Feng,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

2022-03-01

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].

genetics & heredity,biochemistry & molecular biology
Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Pengzhao Shang,Rui Gao,Yijia Zhu,Xiaorui Zhang,Yang Wang,Minji Guo,Hui Peng,Min Wang,Juan Zhang

DOI: https://doi.org/10.1016/j.apsb.2024.02.014

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.09.008.].
Corrigendum to “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” [Genes Dis DOI: 10.1016/j.gendis.2020.07.005]

Xiujin Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Shi Feng,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2021.09.001

2022-03-01

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.].

genetics & heredity,biochemistry & molecular biology
Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review

Zhi-Hua Yang,Bin Wang,Qian Ma,Lin Wang,Ya-Xin Lin,Hai-Feng Yan,Zi-Xuan Fan,Hao-Jia Chen,Zhao Ge,Feng Zhu,Hui-Jie Wang,Bao-Nan Zhang,Hai-Dong Sun,Li-Min Feng

DOI: https://doi.org/10.3389/fphar.2021.770125

IF: 5.6

2021-10-25

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.668407.].

pharmacology & pharmacy
Author Correction to ‘FGF4 Protects the Liver from Immune-Mediated Injury by Activating CaMKKβ-PINK1 Signal Pathway to Inhibit Hepatocellular Apoptosis’ [acta Pharmaceutica Sinica B 14(2024)1605-1623]

Zhifeng Huang,Tongtong Pan,Liang Xu,Lu Shi,Xiong Ma,Liya Zhou,Luyao Wang,Jiaojiao Wang,Guoqing Zhu,Dazhi Chen,Lingtao Song,Xiaomin Pan,Xiaodong Wang,Xiaokun Li,Yongde Luo,Yongping Chen

DOI: https://doi.org/10.1016/j.apsb.2024.04.008

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2023.12.012.].
Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Zekun Li,Yongchun Pan,Shiyu Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qin Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Correction: Hou, J., Et Al. Anti-Inflammatory Effects of Aurantio-Obstusin from Seed of Cassia Obtusifolia L. Through Modulation of the NF-κB Pathway. Molecules 2018, 23, 3093

Jingyi Hou,Yu Gu,Shuai Zhao,Mengqi Huo,Shifeng Wang,Yanling Zhang,Yanjiang Qiao,Xi Li

DOI: https://doi.org/10.3390/molecules24040745

IF: 4.6

2019-01-01

Molecules

Abstract:The authors wish to make the following correction to their paper [...]
Erratum: Analysis on the medication rule of traditional Chinese medicine in the treatment of COVID-19 patients: Erratum

DOI: https://doi.org/10.1097/HM9.0000000000000073

Abstract:[This corrects the article DOI: 10.1097/HM9.0000000000000030.].
Erratum to 'Dietary Hesperidin Suppresses Lipopolysaccharide-Induced Inflammation in Male Mice'

DOI: https://doi.org/10.1177/11786469241276659

2024-09-05

Abstract:[This corrects the article DOI: 10.1177/11786469221128697.].
Corrigendum to “Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus”

Ruiqi Tang,Lanjuan Li

DOI: https://doi.org/10.1155/2021/9756586

2021-06-04

Canadian Journal of Infectious Diseases and Medical Microbiology

Abstract:[This corrects the article DOI: 10.1155/2021/6632266.].

infectious diseases,microbiology

Erratum: Author correction to "Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry" [Acta Pharmaceutica Sinica B 10 (2020) 789-798]

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Author correction to ‘Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects’ [Acta Pharmaceutica Sinica B 13 (2023) 2138–2151]

Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747]

Correction: Corrigendum: Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae

Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

RETRACTED: Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes Dis DOI: 10.1016/J.gendis.2020.07.005]

Author correction to ‘Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy’ [Acta Pharmaceutica Sinica B 11 (2021) 3508–3526]

Erratum: Author correction to 'Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' [Acta Pharm Sin B 12 (2022) 4458-4471]

Corrigendum to “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” [Genes & Diseases 9(2022) 443-455]

Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Corrigendum to “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” [Genes Dis DOI: 10.1016/j.gendis.2020.07.005]

Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review

Author Correction to ‘FGF4 Protects the Liver from Immune-Mediated Injury by Activating CaMKKβ-PINK1 Signal Pathway to Inhibit Hepatocellular Apoptosis’ [acta Pharmaceutica Sinica B 14(2024)1605-1623]

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Correction: Hou, J., Et Al. Anti-Inflammatory Effects of Aurantio-Obstusin from Seed of Cassia Obtusifolia L. Through Modulation of the NF-κB Pathway. Molecules 2018, 23, 3093

Erratum: Analysis on the medication rule of traditional Chinese medicine in the treatment of COVID-19 patients: Erratum

Erratum to 'Dietary Hesperidin Suppresses Lipopolysaccharide-Induced Inflammation in Male Mice'

Corrigendum to “Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus”

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]